Birdwatch Note
2023-03-18 19:01:30 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
COVID-19 vaccines underwent robust randomized controlled trials involving over 70,000 enrollees. Safety and efficacy endpoints were met. Post marketing surveillance has further confirmed safety https://www.nejm.org/doi/full/10.1056/nejmoa2034577 https://www.nejm.org/doi/full/10.1056/nejmoa2110345
Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1637147940035674113
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1637167359386419202
- noteId - 1637167359386419202
- participantId -
- noteAuthorParticipantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31 Participant Details
- createdAtMillis - 1679166090233
- tweetId - 1637147940035674113
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- COVID-19 vaccines underwent robust randomized controlled trials involving over 70,000 enrollees. Safety and efficacy endpoints were met. Post marketing surveillance has further confirmed safety https://www.nejm.org/doi/full/10.1056/nejmoa2034577 https://www.nejm.org/doi/full/10.1056/nejmoa2110345
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-18 19:01:30 UTC (1679166090233) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-19 04:40:19 UTC (1679200819065) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-18 18:32:13 -0500 | Rating Details | |
| 2023-03-18 18:07:28 -0500 | Rating Details | |
| 2023-03-18 16:52:40 -0500 | Rating Details | |
| 2023-03-18 16:41:39 -0500 | Rating Details | |
| 2023-03-18 16:24:52 -0500 | Rating Details | |
| 2023-03-18 15:02:52 -0500 | Rating Details | |
| 2023-03-18 14:38:30 -0500 | Rating Details | |
| 2023-03-18 14:21:30 -0500 | Rating Details | |
| 2023-03-18 14:18:55 -0500 | Rating Details | |
| 2023-03-18 14:08:19 -0500 | Rating Details | |
| 2023-03-18 14:07:16 -0500 | Rating Details | |
| 2023-03-19 12:00:14 -0500 | Rating Details | |
| 2023-03-19 09:00:29 -0500 | Rating Details | |
| 2023-03-19 03:46:11 -0500 | Rating Details | |
| 2023-03-19 01:57:53 -0500 | Rating Details | |
| 2023-03-18 22:02:29 -0500 | Rating Details | |
| 2023-03-18 19:58:01 -0500 | Rating Details | |
| 2023-03-18 14:38:30 -0500 | Rating Details | |
| 2023-03-18 15:02:52 -0500 | Rating Details | |
| 2023-03-19 03:46:11 -0500 | Rating Details | |
| 2023-03-18 22:02:29 -0500 | Rating Details | |
| 2023-03-19 01:57:53 -0500 | Rating Details | |
| 2023-03-18 14:08:19 -0500 | Rating Details | |
| 2023-03-18 16:41:39 -0500 | Rating Details | |
| 2023-03-18 18:07:28 -0500 | Rating Details | |
| 2023-03-18 19:58:01 -0500 | Rating Details | |
| 2023-03-18 16:52:40 -0500 | Rating Details | |
| 2023-03-18 14:21:30 -0500 | Rating Details | |
| 2023-03-18 14:18:55 -0500 | Rating Details | |
| 2023-03-18 14:07:16 -0500 | Rating Details | |
| 2023-03-19 09:00:29 -0500 | Rating Details | |
| 2023-03-19 12:00:14 -0500 | Rating Details | |
| 2023-03-18 16:24:52 -0500 | Rating Details | |
| 2023-03-18 18:32:13 -0500 | Rating Details |